Physician profile
Adam Barker
NPI 1225203896
$5,585.35
in general payments reported to CMS, 2019-2025
15 companies · $79.93 in 2025
The $79.93 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2022: $117 · 2023: $34.89 · 2024: $5,246 · 2025: $79.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,106 · Travel and Lodging: $888 · Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,106.35 |
| Travel and Lodging | $888.03 |
| Food and Beverage | $366.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,136.19 | 2024 | |
| Braintree Laboratories, INC. | $93.88 | 2019-2024 | Sutab, Suflave |
| Shire North American Group INC | $45.06 | 2019 | |
| Phathom Pharmaceuticals, INC. | $42.69 | 2024-2025 | Voquezna |
| Molli Surgical (US) INC | $40.25 | 2022 | |
| Abbvie INC. | $38.72 | 2024 | |
| Merck Sharp & Dohme LLC | $37.22 | 2019-2022 | |
| Smith+Nephew, INC. | $32.54 | 2019-2025 | Pico 7 |
| Pacira Pharmaceuticals Incorporated | $27.09 | 2025 | Exparel |
| Thd America, INC. | $18.15 | 2024 | |
| Acera Surgical, INC. | $16.62 | 2025 | Restrata Wound Matrix |
| Avanos Medical | $16.45 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.50 | 2019 | |
| W. L. Gore & Associates, INC. | $14.29 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Axonics, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.